Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase
- PMID: 9528864
- DOI: 10.1038/sj.onc.1201882
Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase
Abstract
The expression of telomerase, the enzyme that synthesizes telomeric DNA de novo, is suppressed in normal somatic human cells but is reactivated during tumorigenesis. This reactivation appears to arrest the normal loss of telomeric DNA incurred as human cells divide. Since continual loss of telomeric DNA is predicted to eventually limit cell proliferation, activation of telomerase in cancer cells may represent an important step in the acquisition of the cell immortalization which occurs during tumor progression. The telomerase holoenzyme is composed of both RNA and protein subunits. In humans, mRNA expression of hTERT (hEST2), the candidate telomerase catalytic subunit gene, appears to parallel the levels of telomerase enzyme activity, suggesting that induction of hTERT is necessary and perhaps sufficient for expression of telomerase activity in tumor cells. To test this model directly, we ectopically expressed an epitope-tagged version of hTERT in telomerase-negative cells and show that telomerase activity was induced to levels comparable to those seen in immortal telomerase-positive cells and that the expressed hTERT protein was physically associated with the cellular telomerase activity. We conclude that synthesis of the hTERT telomerase subunit represents the rate-limiting determinant of telomerase activity in these cells and that this protein, once expressed, becomes part of the functional telomerase holoenzyme.
Similar articles
-
Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.Cancer Res. 2001 Jul 15;61(14):5529-36. Cancer Res. 2001. PMID: 11454703
-
Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms.Br J Cancer. 1999 Jun;80(8):1156-61. doi: 10.1038/sj.bjc.6690480. Br J Cancer. 1999. PMID: 10376966 Free PMC article.
-
Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer.Clin Cancer Res. 1998 Jul;4(7):1603-8. Clin Cancer Res. 1998. PMID: 9676833
-
[Structure and regulation mechanisms of telomerase].Nihon Rinsho. 1998 May;56(5):1102-7. Nihon Rinsho. 1998. PMID: 9613104 Review. Japanese.
-
Non-telomeric activities of telomerase.Mol Biosyst. 2011 Apr;7(4):1013-23. doi: 10.1039/c0mb00268b. Epub 2011 Feb 1. Mol Biosyst. 2011. PMID: 21283914 Review.
Cited by
-
TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms.Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. Sci Rep. 2015. PMID: 26061100 Free PMC article.
-
Dose-dependent cytotoxic effects of boldine in HepG-2 cells-telomerase inhibition and apoptosis induction.Molecules. 2015 Feb 24;20(3):3730-43. doi: 10.3390/molecules20033730. Molecules. 2015. PMID: 25719742 Free PMC article.
-
CTCF binds the proximal exonic region of hTERT and inhibits its transcription.Nucleic Acids Res. 2005 Dec 2;33(21):6850-60. doi: 10.1093/nar/gki989. Print 2005. Nucleic Acids Res. 2005. PMID: 16326864 Free PMC article.
-
Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia.J Clin Pathol. 2003 Jan;56(1):31-5. doi: 10.1136/jcp.56.1.31. J Clin Pathol. 2003. PMID: 12499429 Free PMC article.
-
Robust activation of the human but not mouse telomerase gene during the induction of pluripotency.FASEB J. 2010 Aug;24(8):2702-15. doi: 10.1096/fj.09-148973. Epub 2010 Mar 30. FASEB J. 2010. PMID: 20354136 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources